These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 220843)

  • 1. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
    Georgiev VP; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopaminergic and GABA-ergic interactions in seizure susceptibility.
    György L
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):280-6. PubMed ID: 526081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
    Bartholini G; Scatton B; Zivkovic B
    Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
    Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1988; 14(2):56-62. PubMed ID: 2851915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of various new GABAergics on motor and oral stereotypes with apomorphine in the rat].
    Vamvakidès A; Kassianidès A; Papadopoulou-Daifoti Z
    J Pharmacol; 1985; 16(4):403-11. PubMed ID: 4094437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
    Sethy VH
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
    Georgiev V
    Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
    Costentin J
    Encephale; 1979; 5(2):121-49. PubMed ID: 38958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the cerebral dopaminergic neurotransmission for the individual differences in learning and memory (experiments on rats).
    Kehayov R; Markovska V; Kamburova T
    Acta Physiol Pharmacol Bulg; 1989; 15(1):76-82. PubMed ID: 2549763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
    Roussinov KS; Lazarova MB
    Acta Physiol Pharmacol Bulg; 1978; 4(3):43-9. PubMed ID: 220842
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of combined treatment with dopaminergic and GABA-ergic drugs on the threshold for maximal electroconvulsions in mice.
    Czuczwar SJ
    Pol J Pharmacol Pharm; 1981; 33(1):25-35. PubMed ID: 6265890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gamma-aminobutyric acid metabolism in different brain structures by cholinergic and adrenergic drugs.
    Balakleevsky AI; Bobrova NP; Shevtchenko NV
    Ann Ist Super Sanita; 1978; 14(1):133-8. PubMed ID: 756168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Biol Psychiatry; 1982 Aug; 17(8):937-46. PubMed ID: 6288127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons.
    Cools AR; Jaspers R; Kolasiewicz W; Sontag KH; Wolfarth S
    Behav Brain Res; 1983 Jan; 7(1):39-49. PubMed ID: 6297521
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover].
    Bernasconi R; Steulet AF; Aryee D; Martin P; Leonhardt T; Bischoff S; Maitre L
    Encephale; 1989; 15(4):377-85. PubMed ID: 2572414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.